153 related articles for article (PubMed ID: 35014175)
21. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
Camici M; Giordani R; Morelli E; Meriggioli M; Balestri PL; Barsotti G; Sagripanti A
Minerva Med; 1998; 89(11-12):405-9. PubMed ID: 10212664
[TBL] [Abstract][Full Text] [Related]
22. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 2 medium cutoff dialyzers versus on-line hemodiafiltration regarding depurative ability and albumin loss: An uncontrolled clinical research.
Martínez-Miguel P; Gimena Muñoz R; Barrionuevo González M; López-Ongil S; Moro MÁ; Lizasoain I; Rodríguez-Puyol D; García Segura JM
Artif Organs; 2023 Mar; 47(3):589-594. PubMed ID: 36420938
[TBL] [Abstract][Full Text] [Related]
24. Medium Cut-Off Dialyzer versus Eight Hemodiafiltration Dialyzers: Comparison Using a Global Removal Score.
Maduell F; Rodas L; Broseta JJ; Gomez M; Xipell M; Guillen E; Montagud-Marrahi E; Arias-Guillén M; Fontseré N; Vera M; Rico N
Blood Purif; 2019; 48(2):167-174. PubMed ID: 30943486
[TBL] [Abstract][Full Text] [Related]
25. Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules
.
Belmouaz M; Diolez J; Bauwens M; Duthe F; Ecotiere L; Desport E; Bridoux F
Clin Nephrol; 2018 Jan; 89 (2018)(1):50-56. PubMed ID: 28853700
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
27. Safety and Efficacy of Tinzaparin Anticoagulation during Nocturnal Hemodialysis.
Bugeja A; Harris S; McCormick B; Brown PA; Liberty C; Krepelka T; St-Cyr G; Akbari A
Am J Nephrol; 2019; 50(4):255-261. PubMed ID: 31434091
[TBL] [Abstract][Full Text] [Related]
28. Dose titration study of tinzaparin, a low molecular weight heparin, in patients on chronic hemodialysis.
Egfjord M; Rosenlund L; Hedegaard B; Buchardt HL; Stengel C; Gardar P; Andersen L; Andersen L
Artif Organs; 1998 Aug; 22(8):633-7. PubMed ID: 9702313
[TBL] [Abstract][Full Text] [Related]
29. Clinical safety and anticoagulation efficacy of low-molecular-weight heparins in chronic hemodialysis patients: a single medical center experience.
Chuang FR; Chen TC; Lee CH; Ng HY; Wang IK; Chang HW; Chuang PH; Wu CH; Yang CC; Su YJ
Ren Fail; 2011; 33(10):990-7. PubMed ID: 22013932
[TBL] [Abstract][Full Text] [Related]
30. The effect of hemodiafiltration vs. high-flux hemodialysis on alpha 1-microglobulin level and dialysate albumin loss using a dialyzer surface area of 2.6 m².
ElSayed H; Fathy M; Khedr A; Hussein HS; Elbraky A; ElSharkawy M
Egypt J Immunol; 2023 Jul; 30(3):124-133. PubMed ID: 37440533
[TBL] [Abstract][Full Text] [Related]
31. Performance of hemodialysis with novel medium cut-off dialyzers.
Kirsch AH; Lyko R; Nilsson LG; Beck W; Amdahl M; Lechner P; Schneider A; Wanner C; Rosenkranz AR; Krieter DH
Nephrol Dial Transplant; 2017 Jan; 32(1):165-172. PubMed ID: 27587605
[TBL] [Abstract][Full Text] [Related]
32. [Antithrombotic activity of low molecular weight heparin (enoxaparin) during hemodialysis in patients with terminal kidney failure].
Przedlacki J; Bogdańska-Straszyńska B; Sawicka B; Włodarczyk D; Sladowska B; Ajewski M; Wasiak K; Gellert R
Pol Arch Med Wewn; 1994 Jun; 91(6):438-45. PubMed ID: 7971464
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the anticoagulant effect of low-molecular-weight heparins based on the anti-Xa level during haemodialysis.
Tao M; Zheng D; Liang X; Ye M; Liu Y; Li Y; Shen H; He Q
Nephrology (Carlton); 2020 Sep; 25(9):723-729. PubMed ID: 31999031
[TBL] [Abstract][Full Text] [Related]
34. Dose effect relationship of reviparin in chronic hemodialysis: a crossover study versus nadroparin.
Reach I; Luong N; Chastang C; Chakroun M; Mirshahi S; Mirshahi MC; Soria J; Desmichels D; Baumelou A
Artif Organs; 2001 Jul; 25(7):591-5. PubMed ID: 11493282
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effect of high flux dialyzer surface area 2.6m2 in high flux hemodialysis and hemodiafiltration.
ElSayed H; Mohamed A; Aref HM; Hussein HS; Gouda K
Egypt J Immunol; 2024 Jan; 31(1):184-192. PubMed ID: 38225777
[TBL] [Abstract][Full Text] [Related]
36. Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration.
Tangvoraphonkchai K; Riddell A; Davenport A
Hemodial Int; 2018 Apr; 22(2):192-200. PubMed ID: 28762633
[TBL] [Abstract][Full Text] [Related]
37. Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study.
Kessler M; Gangemi C; Gutierrez Martones A; Lacombe JL; Krier-Coudert MJ; Galland R; Kielstein JT; Moureau F; Loughraieb N
Hemodial Int; 2013 Apr; 17(2):282-93. PubMed ID: 22925178
[TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration.
Rodriguez A; Morena M; Bargnoux AS; Chenine L; Leray-Moragues H; Cristol JP; Canaud B
Artif Organs; 2021 Aug; 45(8):E280-E292. PubMed ID: 33507535
[TBL] [Abstract][Full Text] [Related]
39. Citrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap.
Buturovic-Ponikvar J; Gubensek J; Ponikvar R
Int J Artif Organs; 2008 Apr; 31(4):323-8. PubMed ID: 18432588
[TBL] [Abstract][Full Text] [Related]
40. Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1.
Lavainne F; Meffray E; Pepper RJ; Néel M; Delcroix C; Salama AD; Fakhouri F
Nephrol Dial Transplant; 2014 Jun; 29(6):1225-31. PubMed ID: 24516233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
